CA72-4 Test: Clinical Significance of This Tumor Marker in Gastric Cancer
CA72-4 Test: Clinical Significance of This Tumor Marker in Gastric Cancer
Tumor markers are important tools for monitoring certain cancers, and CA72-4 (Cancer Antigen 72-4) is particularly relevant in gastric cancer. While not used for standalone diagnosis, CA72-4 provides valuable information for treatment monitoring, recurrence detection, and combined interpretation with other markers.
1. What Is CA72-4?
CA72-4 is a high-molecular-weight mucin-type glycoprotein. It is minimally expressed in normal tissues but can increase in certain malignancies, especially gastric cancer.
Key points:
- Not a primary diagnostic test: Used mainly in patients with already diagnosed malignancy
- Clinical applications:
- Monitoring response to therapy
- Tracking recurrence
- Supporting interpretation alongside other tumor markers
2. Clinical Applications of CA72-4
✔ Gastric Cancer
- CA72-4 shows a relatively high specificity for gastric cancer, although sensitivity is moderate.
- Best used in combination with other markers like CEA and CA19-9 to improve clinical utility.
✔ Ovarian Cancer (Mucinous Type)
- Some mucinous ovarian cancers also elevate CA72-4
- Can be interpreted alongside CA125 for reference
✔ Other Gastrointestinal Malignancies
- Reported elevations in:
- Colorectal cancer
- Pancreatic cancer
- Biliary tract cancer
- In these cases, CA72-4 is not highly specific and should be considered supportive.
3. Test Method
- Specimen: Serum
- Methods:
- ECLIA (Electrochemiluminescence Immunoassay)
- CLIA or ELISA-based immunoassays
- Automated immunoassay analyzers are used, but results may vary across laboratories and methods, so direct comparison requires caution.
4. Reference Range
- Varies by laboratory, but generally:
CA72-4 < 6.9–7.0 U/mL - Important: Trends over time are more meaningful than a single absolute value.
5. Causes of Elevated CA72-4
🔺 Malignant Causes
- Gastric cancer
- Mucinous ovarian cancer
- Colorectal cancer
- Pancreatic cancer
🔺 Benign Causes (Mild Elevation)
- Gastritis, gastric ulcers
- Pancreatitis
- Ovarian cysts
- Liver disease
- Pulmonary disease
- Smoking
Interpretation caution: A single elevated value does not confirm malignancy.
6. Limitations of CA72-4
- ❌ Not suitable for screening
- ❌ Early gastric cancer may show normal levels
- ❌ Variability exists across labs, reagents, and methods
- Always interpret alongside: Imaging studies, biopsy results, and clinical evaluation
7. Key Clinical Points
- CA72-4 is most useful for follow-up rather than diagnosis
- In gastric cancer, observe:
- Post-surgical decrease
- Changes during chemotherapy
- Re-elevation indicating possible recurrence
- Combined interpretation with CEA and CA19-9 improves clinical decision-making
8. Summary
CA72-4 is a supportive tumor marker primarily for gastric and other gastrointestinal malignancies.
Its value lies in monitoring trends over time and correlation with other markers and clinical findings, rather than relying on a single test result.
Always consult a specialist and consider additional testing before drawing conclusions from CA72-4 values alone.
📚 References
- Duffy MJ. Tumor markers in clinical practice: a review focusing on common solid cancers. Med Princ Pract. 2013;22(1):4–11.
- Sturgeon CM, et al. National Academy of Clinical Biochemistry guidelines for use of tumor markers in gastric cancer. Clin Chem. 2008;54(12):e11–e79.
- Molina R, et al. Tumor markers (CEA, CA19-9, CA72-4) in patients with gastric cancer. Tumour Biol. 2005;26(6):279–286.
- Locker GY, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24(33):5313–5327.